• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[获得性大疱性表皮松解症:通过连接抗原的光学免疫荧光检测进行诊断及维生素E治疗]

[Epidermolysis bullosa acquisita: diagnosis by optic immunofluorescent demonstration of junctional antigens and vitamin E treatment].

作者信息

Hintner H, Schuler G, Fritsch P

出版信息

Hautarzt. 1982 Jun;33(6):310-4.

PMID:6179897
Abstract

In a patient with epidermolysis bullosa acquisita the characteristic dermolytic cleavage was demonstrated by electron microscopy and by mapping of antigenic determinants (type IV collagen, laminin, bullous pemphigoid antigen) of the dermal-epidermal junction. The latter method represents a rapid and reliable way to determine the cleavage plane in diseases which display subepidermal blister formation at the light-microscopic level. The classification of epidermolysis bullosa acquisita is still under dispute. Due to its highly characteristic clinical, ultrastructural, and immunologic features and pending further experimental data, epidermolysis bullosa acquisita should be regarded as a separate disease entity; its lumping together with cicatricial pemphigoid, as proposed by some authors appears speculative. Therapy of epidermolysis bullosa acquisita is generally regarded as difficult; following a 3-year course of high dose vitamin E therapy our patient underwent complete clearing; the possibility of a spontaneous remission, on the other hand, cannot be unequivocally ruled out.

摘要

在一位获得性大疱性表皮松解症患者中,通过电子显微镜以及对真皮 - 表皮连接处抗原决定簇(IV型胶原、层粘连蛋白、大疱性类天疱疮抗原)的定位,证实了特征性的真皮溶解性分离。后一种方法是在光镜水平显示表皮下疱形成的疾病中确定分离平面的快速且可靠的方法。获得性大疱性表皮松解症的分类仍存在争议。由于其具有高度特征性的临床、超微结构和免疫学特征,且有待进一步的实验数据,获得性大疱性表皮松解症应被视为一种独立的疾病实体;一些作者提议将其与瘢痕性类天疱疮归为一类,这似乎是推测性的。获得性大疱性表皮松解症的治疗通常被认为是困难的;在接受了3年高剂量维生素E治疗后,我们的患者完全治愈;另一方面,不能明确排除自发缓解的可能性。

相似文献

1
[Epidermolysis bullosa acquisita: diagnosis by optic immunofluorescent demonstration of junctional antigens and vitamin E treatment].[获得性大疱性表皮松解症:通过连接抗原的光学免疫荧光检测进行诊断及维生素E治疗]
Hautarzt. 1982 Jun;33(6):310-4.
2
Epidermolysis bullosa acquisita: an autoimmune disease with distinctive immunoultrastructural features.获得性大疱性表皮松解症:一种具有独特免疫超微结构特征的自身免疫性疾病。
Cutis. 1983 Dec;32(6):521-7.
3
Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases.机械性大疱性疾病中真皮-表皮交界处抗原决定簇的免疫荧光定位
J Invest Dermatol. 1981 Feb;76(2):113-8. doi: 10.1111/1523-1747.ep12525447.
4
Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl.儿童获得性大疱性表皮松解症。一名5岁女孩的病例发现。
Arch Dermatol. 1987 Jun;123(6):772-6.
5
[Epidermolysis bullosa acquisita--manifestations in otorhinolaryngology].[获得性大疱性表皮松解症——耳鼻咽喉科表现]
Laryngol Rhinol Otol (Stuttg). 1983 Oct;62(10):456-62.
6
Epidermolysis bullosa acquisita with negative direct immunofluorescence.直接免疫荧光检查阴性的获得性大疱性表皮松解症
Arch Dermatol. 1985 Sep;121(9):1183-5.
7
Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.来自一名获得性致残性大疱性表皮松解症患者的自身抗体被动转移可诱导新生小鼠皮肤发生特异性改变。
Arch Dermatol. 1995 May;131(5):590-5.
8
[Acquired epidermolysis bullosa. A clinico-pathologic study].[获得性大疱性表皮松解症。一项临床病理研究]
Hautarzt. 1988 Jun;39(6):355-62.
9
Persistent subepidermal blistering in split-thickness skin graft sites. Ultrastructural and antigenic features simulating dystrophic or immunofluorescence-negative acquired epidermolysis bullosa.厚皮片移植部位持续存在的表皮下水疱。超微结构和抗原特征类似于营养不良性或免疫荧光阴性的获得性大疱性表皮松解症。
Arch Dermatol. 1988 Feb;124(2):244-9.
10
A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.一种鉴别表皮下大疱性疾病的实用技术:通过激光扫描共聚焦显微镜对体内结合的IgG进行定位
Arch Dermatol. 2003 Aug;139(8):1007-11. doi: 10.1001/archderm.139.8.1007.